Toronto company selling OnX, an AI software platform that analyzes raw ultrasound signals from point-of-care devices to screen for structural liver disease.
Canadian innovation builds a brighter tomorrow.
Toronto company selling OnX, an AI software platform that analyzes raw ultrasound signals from point-of-care devices to screen for structural liver disease.
Ontario Business Corp. ONCOUSTICS INC., status Active, registered office in Toronto, ON — matches the company's own Bay Street address. ised-isde.canada.ca
Raised $5.5M CAD ($4.3M USD) in seed funding in July 2022, co-led by Creative Ventures and Saltagen Ventures. betakit.com
Received co-investment from DIGITAL, Canada's Global Innovation Cluster for digital technologies, to advance its AI-driven tissue characterization platform (no amount disclosed). oncoustics.com
Clinical partners for its OnX liver assessment platform include University Health Network's Ajmera Transplant Centre and the Toronto Centre for Liver Disease. oncoustics.com
OnX has been introduced to over 100 clinics and hundreds of key opinion leaders globally while the company files FDA submissions for the product. oncoustics.com
Products Oncoustics publishes on its own site. Each card links to the page it was taken from.
AI ultrasound diagnostics
Company describes an AI-powered software suite that analyzes raw ultrasound signals from point-of-care devices to detect and monitor liver disease (fibrosis, steatosis, inflammation, nodules) in about 5 minutes.
Learn moreAnnounced rounds only, newest first. Undisclosed amounts are shown as undisclosed.
Jul 21, 2022
Investors: Creative Ventures, Saltagen Ventures, NorthSpring Capital Partners, Fraser Kearney Capital Corp., Pallasite Ventures
Publicly announced partnerships.
Clinical partners supporting development of the OnX liver assessment platform, including a new liver inflammation evaluation tool.
Government support actually received. Unpublished amounts are left out.
DIGITAL Supercluster — co-investment for AI-driven tissue characterization
Industrial Research Assistance Program – Innovation Assistance Program, National Research Council Canada
Innovation Assistance Program, National Research Council Canada
Industrial Research Assistance Program – Innovation Assistance Program, National Research Council Canada
Oncoustics received co-investment from DIGITAL, Canada's Global Innovation Cluster for digital technologies, to advance its AI-driven tissue characterization platform and will lead a new Canadian AI in Healthcare Consortium. Clinical partners include University Health Network's Ajmera Transplant Centre and the Toronto Centre for Liver Disease.
Oncoustics closed a $5.5M CAD ($4.3M USD) seed round co-led by Creative Ventures and Saltagen Ventures, with NorthSpring Capital Partners, Fraser Kearney Capital Corp. and Pallasite Ventures participating, to advance its AI platform for liver disease detection from ultrasound.
Sourced from the company's own pages or announcements.
Beth Rogozinski
Chief Executive Officer
Terms the company uses about its own work.
Other companies in AI.
Discover companies, track funding, explore career opportunities and stay informed about Canada’s growing tech ecosystem.
